CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL- positive chronic myeloid leukemia 期刊论文
AUTOPHAGY, 2015, 卷号: 11, 期号: 2
作者:  Zeng, Xian;  Zhao, Hui;  Li, Yubin;  Fan, Jiajun;  Sun, Yun
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/19
Cost-Effectiveness Study Comparing Imatinib with Interferon-alpha for Patients with Newly Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) from the Chinese Public Health-Care System Perspective (CPHSP) 期刊论文
VALUE IN HEALTH, 2009, 卷号: 12
作者:  Chen, Zi;  Wang, Chun;  Xu, Xiaoping;  Feng, Weiwei
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
Imatinib is cost-effective comparing to interferon-(IFN) for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the chinese public healthcare system perspective. 会议论文
作者:  Wang, Chun;  Chen, Zi;  Feng, Weiwei
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
Imatinib versus interferon-alpha (IFN) for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the chinese public healthcare system perspective: 12 months cost and cost per responder analyses. 会议论文
作者:  Wang, Chun;  Chen, Zi;  Feng, Weiwei
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/19
Comparison of 12-month treatment costs for patients with advanced phase chronic myeloid leukemia (CML) in China: Imatinib (IM) vs. chemotherapy (Chemo) plus interferon-(IFN) in accelerated phase (AP) CML and IM vs. chemo in blast crisis (BC) CML. 会议论文
作者:  Chen, Zi;  Wang, Chun;  Feng, Weiwei
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/27
Comparison of 12-month treatment costs for patients with advanced phase chronic myeloid leukemia (CML) in China: Imatinib (IM) vs. chemotherapy (Chemo) plus interferon-(IFN) in accelerated phase (AP) CML and IM vs. chemo in blast crisis (BC) CML. 会议论文
作者:  Chen, Zi;  Wang, Chun;  Feng, Weiwei
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/27


©版权所有 ©2017 CSpace - Powered by CSpace